SmartPilot gets FDA 510(k) clearance
Sensaco’s Impact on the FDA Clearance Process of a Digital Add-on for Auto-injectors
Securing FDA 510(k) clearance requires strong technology and thorough regulatory work. Sensaco helped their client navigate this process by:
- Advising on strategy and building a skilled team.
- Preparing detailed documentation for FDA submission, including cybersecurity, software validation, risk analysis, and IFU.
- Overseeing project reviews and taking on interim management roles.
- Designing security frameworks to protect patient data.
- Leading workshops to align solutions with user needs and regulations.
Thanks to Sensaco’s support, SmartPilot earned FDA 510(k) clearance, proving its safety and effectiveness. This separated the autoinjector’s regulatory path from its digital parts, making market entry easier for Ypsomed’s partners and lowering risk.
- Cybersecurity, Medical Device, FDA 510(k) Approval, Software
- Ypsomed Delivery Systems
- 2025
- Switzerland, US, EU
Challenge
With a new and innovative product, it was a great challenge to find a predicate device for 510(k) clearance fitting the class of digital data capture for injectors. The legal manufacturer had to show throughout the approval process, that the device and its surrounding ecosystem works as intended and delivers a secure, safe and effective solution to patients and healthcare providers.
Ypsomed’s solution is a worlds’ first approach to device deployment and a cloud-connected ecosystem at large scale. Supporting the different, existing mechanical injector platforms was needed for all pharma clients wishing to integrate the digital solution into their systems using software development kits for mobile apps and proven REST APIs for cloud connectivity.
Solution
The Power of Expert Consulting and Connected Technology in Modern Healthcare
Securing FDA clearance for digital and medical devices is a milestone that opens doors to safer, more effective healthcare solutions. Sensaco’s role in supporting Ypsomed’s SmartPilot journey highlights how expert consulting, rigorous documentation, and cutting-edge cybersecurity enable innovation and regulatory success. Let’s explore how Sensaco’s contributions helped pave the way for FDA 510(k) clearance and the transformative benefits these digital solutions bring to Ypsomed’s clients.
Sensaco’s Impact on the FDA Clearance Process
Achieving FDA 510(k) clearance demands not only technological excellence but also meticulous preparation across cybersecurity, risk management, and regulatory documentation. Sensaco played a pivotal role in guiding their client through this complex landscape by:
- Consulting and Team Build-Up: Providing strategic advice and assembling a multidisciplinary team to address regulatory requirements efficiently.
- Comprehensive Documentation: Preparing detailed records for FDA clearance, covering cybersecurity architecture, software validation, risk analysis, and Instructions for Use (IFU).
- Project Review and Interim Management: Ensuring that every aspect of the project met stringent regulatory standards through ongoing reviews and interim leadership roles.
- Cybersecurity Architecture and Design: Building robust security frameworks to protect patient data and device integrity throughout the product lifecycle.
-
Customer-Centric Workshops: Facilitating workshops to tailor the solution design to end-user needs and regulatory expectations
With Sensaco’s expertise, SmartPilot successfully achieved FDA 510(k) clearance, confirming that it is as safe and effective as legally marketed predicate devices. This accomplishment decouples the regulatory process for the autoinjector from the digital component, streamlining market access for Ypsomed’s pharmaceutical partners and reducing risk.
Key Client Segments Benefiting from Ypsomed’s Digital Solutions
- Pharmaceutical and biotechnology companies conducting clinical trials
- Healthcare providers and clinics seeking advanced medication administration solutions
- Patients managing chronic conditions requiring injectable therapies
- Contract research organizations (CROs) supporting data-driven research
- Pharmaceutical sales and marketing teams aiming for product differentiation
- Healthcare technology integrators and platform developers
The Advantages of Digital Health Solutions for Ypsomed’s Clients
FDA-cleared digital solutions like SmartPilot and CliniPilot are transforming the way pharmaceutical companies and patients approach therapy and clinical trials in a number of ways:
- Data-Driven Decisions: Connected devices automatically capture accurate, unbiased injection data, eliminating manual documentation and human error. This robust data supports better research, reduces trial costs, and improves quality.
- Enhanced Patient Experience: User-centered, ergonomic design ensures an effortless injection experience and step-by-step guidance, empowering patients to confidently self-manage their therapy.
- Seamless Integration: The platform integrates with major Electronic Data Capture (EDC) systems, enabling real-time monitoring, adherence tracking, and streamlined workflows for clinical trials.
- Customizable Solutions: Ypsomed’s digital platform can be tailored to disease-, patient-, and brand-specific needs, offering flexibility for pharmaceutical partners to differentiate products and boost commercial success.
- Regulatory Confidence and Cybersecurity: Adherence to standards like GDPR, HIPAA, ISO 27001/13485/14971, and IEC guidelines ensures data protection, regulatory compliance, and robust cybersecurity throughout the device lifecycle.
In summary, Sensaco’s expertise in regulatory consulting and digital health design has been instrumental not only in achieving FDA clearance for SmartPilot but also in delivering digital solutions that empower Ypsomed’s clients. These solutions drive operational efficiency, enhance patient outcomes, and enable pharmaceutical partners to innovate with confidence in a rapidly evolving healthcare environment.
Results
FDA Device Database: Listing for SmartPilot.
